The Subject Expert Committee of the Central Drugs Standard Control Organisation will allow the Serum Institute of India to conduct trials of the Novavax COVID-19 vaccine in children between the ages of 7 and 11 years. (Business Standard) COVID-19 pandemic in India, COVID-19 vaccination in IndiaCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save